Showing results (141-150 of 382) with videos related to

Sort By:
Pageof 39
Cancer Cell|August 18, 2012
Synergy between PI3K signaling and MYC in Burkitt lymphomagenesisSandrine Sander, Dinis P Calado, Lakshmi Srinivasan, et al.
Genetic Testing and Molecular Biomarkers|March 28, 2013
Detection of mutant NPM1 mRNA in acute myeloid leukemia using custom gene expression arraysMartin H van Vliet, Belinda Dumee, Erik Simons, et al.
International Journal of Cancer|February 18, 2021
Long-term in vitro expansion ensures increased yield of central memory T cells as perspective for manufacturing challengesStefanie Herda, Andreas Heimann, Benedikt Obermayer, et al.
Patterns (New York, N.Y.)|October 25, 2021
Knowledge transfer to enhance the performance of deep learning models for automated classification of B cell neoplasmsNanditha Mallesh, Max Zhao, Lisa Meintker, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|November 3, 2024
Review of preclinical data on hyperthermia treatment in lymphomas and its potential for clinical applicationMoritz V Scharr, Frederik Damm, Paul Krahl, et al.
The International Journal of Biochemistry & Cell Biology|June 5, 2007
Early hematopoietic zinc finger protein-zinc finger protein 521: a candidate regulator of diverse immature cellsHeather M Bond, Maria Mesuraca, Nicola Amodio, et al.
Immunity|December 2, 2015
PI3 Kinase and FOXO1 Transcription Factor Activity Differentially Control B Cells in the Germinal Center Light and Dark ZonesSandrine Sander, Van Trung Chu, Tomoharu Yasuda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2013
PRAME-induced inhibition of retinoic acid receptor signaling-mediated differentiation--a possible target for ATRA response in AML without t(15;17)Lars Bullinger, Richard F Schlenk, Marlies Götz, et al.
Blood|January 6, 2026
Phase 3 study of intensive chemotherapy with or without dasatinib in core-binding factor acute myeloid leukemiaHartmut Döhner, Daniela Späth, Maral Saadati, et al.
Blood|December 24, 2013
Comparing cancer vs normal gene expression profiles identifies new disease entities and common transcriptional programs in AML patientsNicolas Rapin, Frederik Otzen Bagger, Johan Jendholm, et al.
Pageof 39